InteliCare Nears $1M Revenue Milestone with Hardi Deployments

InteliCare Holdings has advanced its aged care technology deployments and is close to appointing a new CEO, signalling a pivotal growth phase. The company also reported progress in commercial talks and product enhancements.

  • Ongoing commercial discussions with mecwacare towards broader agreement
  • Deployment expansion within Hardi Aged Care network including new Seven Hills site
  • CEO recruitment process nearing completion
  • Product upgrades enhancing nurse call integration and AI event analysis
  • Maintained cash position with controlled expenditure during December quarter
An image related to INTELICARE HOLDINGS LIMITED
Image source middle. ©

Commercial Momentum Builds

InteliCare Holdings Ltd (ASX – ICR) has reported steady progress in the December 2025 quarter, advancing its commercial footprint in the aged care sector. Central to this momentum are ongoing negotiations with mecwacare, one of Victoria’s largest not-for-profit aged care providers. Following a successful pilot at the Trescowthick Centre, discussions are focused on finalising a broader commercial agreement to deploy InteliCare’s AI-driven platform across mecwacare’s network of 22 residential facilities.

This potential deal represents a significant opportunity for InteliCare to scale its technology, which leverages smart sensors and artificial intelligence to improve care outcomes and operational efficiencies. While the agreement is not yet formalised, the company expressed optimism about concluding terms soon.

Expanding Deployment Footprint

Alongside mecwacare, InteliCare has continued to deepen its relationship with Hardi Aged Care, deploying its platform at Seven Hills; the fourth of six sites within the Hardi network. This rollout builds on earlier implementations at Manly Vale and Blacktown, where monthly software-as-a-service fees have already commenced. To date, InteliCare has recognised nearly $1 million in hardware and implementation fees from this agreement, with ongoing SaaS revenues expected to grow as the rollout completes.

The company’s structured approach to deployment aims to embed the technology operationally, ensuring scalability and sustained value delivery across the network.

Product Innovation and Operational Efficiency

InteliCare has also made notable strides in product development during the quarter. Enhancements to nurse call integration features and the introduction of a new Installer App utilising LiDAR technology are designed to reduce deployment costs and improve operational efficiency. Updates to the platform’s AI models now support more accurate event analysis and summarisation, reinforcing the solution’s value proposition.

Further development efforts are underway, including advanced detection of resident social isolation and improved wearable device support, aligning with evolving aged care regulations and compliance requirements.

Leadership Transition and Financial Position

Following the departure of former CEO Daniel Pilbrow, InteliCare is nearing the conclusion of its CEO recruitment process. Interim Executive Director Tim Chapman has been steering operations alongside the executive team, preparing the company for its next growth phase. The board has expressed satisfaction with the calibre of candidates and anticipates announcing the new CEO shortly.

Financially, the company reported modest sales receipts of $121,000 for the quarter, with disciplined expense management keeping cash burn in check. InteliCare held $1.05 million in cash and equivalents at quarter-end, positioning it to continue executing its business strategy.

Overall, the December quarter was marked by foundational progress across commercial, operational, and leadership fronts, setting the stage for potential contract finalisations and expanded deployments in the months ahead.

Bottom Line?

With key agreements pending and leadership soon in place, InteliCare is poised for a defining growth chapter.

Questions in the middle?

  • When will the commercial agreement with mecwacare be formally signed and what are its terms?
  • Who will be appointed as the new CEO and what strategic direction will they bring?
  • How quickly can InteliCare convert its expanded pipeline into contracted deployments?